Construction of Novel Immune-Related LncRNA Signature and its Potential Prediction of Immune Status in Hepatocellular Carcinoma

Min Deng(Sun Yat-sen University), Rong-Ping Guo(Sun Yat-sen University), Jiabao Lin(Nanfang Hospital), Wei Wei(Zhujiang Hospital), Shaohua Li(Sun Yat-sen University), Rongce Zhao(Sun Yat-sen University)

Research Square

May 5, 2021

10.21203/rs.3.rs-412155/v1

Cited by 0

Related Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

|JAMA Oncology|2019|559

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

|Journal of Clinical Oncology|2020|217

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

|Therapeutic Advances in Medical Oncology|2021|216

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

|癌症：英文版|2018|189

A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome

|European Journal of Endocrinology|2011|160